ES2154397T3 - Dispositivo de ionoforesis para la administracion transcutanea de un principio activo de tipo oligosacarido anionico. - Google Patents

Dispositivo de ionoforesis para la administracion transcutanea de un principio activo de tipo oligosacarido anionico.

Info

Publication number
ES2154397T3
ES2154397T3 ES96901841T ES96901841T ES2154397T3 ES 2154397 T3 ES2154397 T3 ES 2154397T3 ES 96901841 T ES96901841 T ES 96901841T ES 96901841 T ES96901841 T ES 96901841T ES 2154397 T3 ES2154397 T3 ES 2154397T3
Authority
ES
Spain
Prior art keywords
active principle
pct
electrodes
per
negative electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96901841T
Other languages
English (en)
Inventor
Daniel Muller
Alain Barbier
Henry Saunal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe National Elf Aquitaine
Sanofi SA
Akzo Nobel NV
Original Assignee
Societe National Elf Aquitaine
Sanofi SA
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe National Elf Aquitaine, Sanofi SA, Akzo Nobel NV filed Critical Societe National Elf Aquitaine
Application granted granted Critical
Publication of ES2154397T3 publication Critical patent/ES2154397T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL DISPOSITIVO LLEVA UN ELECTRODO REVERSIBLE, EN CONTACTO CON UN ELEMENTO DE DEPOSITO QUE CONTIENE UN ELECTRODO QUE CONTIENE EL PRINCIPIO ACTIVO OLIGOSACARIDO ANIONICO, PARTICULARMENTE PENTASACARICO, EN FORMA AL MENOS PARCIALMENTE IONIZADA, UN ELECTRODO POSITIVO, SOLO O ASOCIADO A UN RECEPTACULO QUE CONTIENE UN ELECTROLITO, Y UN GENERADOR DE SEÑALES ELECTRICAS QUE SE PUEDE CONECTAR A LOS DOS ELECTRODOS. EL GENERADOR ESTA DISPUESTO PARA APLICAR SEÑALES ELECTRICAS DE TENSION MEDIA ENTRE LOS ELECTRODOS, DE MANERA QUE LA DENSIDAD DE LA CORRIENTE MEDIA GENERADA ENTRE LOS ELECTRODOS ESTA COMPRENDIDA ENTRE 0''05 Y 0''25 M A/CM {SUP,2}. LA CANTIDAD DE PRINCIPIO ACTIVO PRESENTE EN EL ELEMENTO DEL DEPOSITO ASOCIADO DEL ELECTRODO NEGATIVO REPRESENTA ENTRE 0''5 MG Y 12 MG POR CM {SUB,2} DE ELECTRODO Y POR M AH DE CORRIENTE QUE PASA A TRAVES DE 1 CM {SUP,2} DE ELECTRODO.
ES96901841T 1995-01-24 1996-01-24 Dispositivo de ionoforesis para la administracion transcutanea de un principio activo de tipo oligosacarido anionico. Expired - Lifetime ES2154397T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9500757A FR2729574B1 (fr) 1995-01-24 1995-01-24 Dispositif d'ionophorese pour l'administration transcutanee d'un principe actif de type oligosaccharide anionique

Publications (1)

Publication Number Publication Date
ES2154397T3 true ES2154397T3 (es) 2001-04-01

Family

ID=9475415

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96901841T Expired - Lifetime ES2154397T3 (es) 1995-01-24 1996-01-24 Dispositivo de ionoforesis para la administracion transcutanea de un principio activo de tipo oligosacarido anionico.

Country Status (12)

Country Link
US (1) US5928185A (es)
EP (1) EP0805706B1 (es)
JP (2) JP3856240B2 (es)
AT (1) ATE192664T1 (es)
AU (1) AU4626196A (es)
DE (1) DE69608248T2 (es)
DK (1) DK0805706T3 (es)
ES (1) ES2154397T3 (es)
FR (1) FR2729574B1 (es)
GR (1) GR3034097T3 (es)
PT (1) PT805706E (es)
WO (1) WO1996022808A1 (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5797867A (en) * 1996-09-27 1998-08-25 Becton Dickinson And Company Iontophoretic drug delivery system, including method for activating same for attachment to patient
AU780953B2 (en) * 1999-08-30 2005-04-28 Tepha, Inc. Flushable disposable polymeric products
AU2003226605A1 (en) 2002-04-19 2003-11-03 Transpharma Medical Ltd. Handheld transdermal drug delivery and analyte extraction
US7031769B2 (en) * 2003-02-21 2006-04-18 Birch Point Medical, Inc. Dosage control electrode for iontophoresis device
US7477938B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Cosumer Companies, Inc. Device for delivery of active agents to barrier membranes
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US7477941B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of exfoliating the skin with electricity
US7480530B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Device for treatment of barrier membranes
US7479133B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Methods of treating acne and rosacea with galvanic generated electricity
US20040265395A1 (en) * 2003-06-30 2004-12-30 Ying Sun Device for delivery of reducing agents to barrier membranes
US7507228B2 (en) * 2003-06-30 2009-03-24 Johnson & Johnson Consumer Companies, Inc. Device containing a light emitting diode for treatment of barrier membranes
US7476222B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of reducing the appearance of pigmentation with galvanic generated electricity
US7477940B2 (en) * 2003-06-30 2009-01-13 J&J Consumer Companies, Inc. Methods of administering an active agent to a human barrier membrane with galvanic generated electricity
US7486989B2 (en) * 2003-06-30 2009-02-03 Johnson & Johnson Consumer Companies, Inc. Device for delivery of oxidizing agents to barrier membranes
JP2007037868A (ja) * 2005-08-05 2007-02-15 Transcutaneous Technologies Inc 経皮投与装置及びその制御方法
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US8295922B2 (en) * 2005-08-08 2012-10-23 Tti Ellebeau, Inc. Iontophoresis device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
WO2007026672A1 (ja) * 2005-08-29 2007-03-08 Transcu Ltd. イオントフォレーシス用汎用性電解液組成物
KR20080047600A (ko) 2005-09-15 2008-05-29 티티아이 엘뷰 가부시키가이샤 로드형 이온토포레시스 장치
JPWO2007037324A1 (ja) * 2005-09-28 2009-04-09 Ｔｔｉ・エルビュー株式会社 乾燥型イオントフォレーシス用電極構造体
WO2007041118A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoretic device and method of delivery of active agents to biological interface
EP1928542A1 (en) * 2005-09-30 2008-06-11 Tti Ellebeau, Inc. Method and system to detect malfunctions in an iontophoresis device that delivers active agents to biological interfaces
JP2009509659A (ja) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 生体界面への活性物質の送達のイオントフォレーシス装置及び方法
US20070232983A1 (en) * 2005-09-30 2007-10-04 Smith Gregory A Handheld apparatus to deliver active agents to biological interfaces
US20070078375A1 (en) * 2005-09-30 2007-04-05 Transcutaneous Technologies Inc. Iontophoretic delivery of active agents conjugated to nanoparticles
WO2007079193A2 (en) 2005-12-30 2007-07-12 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
JP2009542685A (ja) * 2006-07-05 2009-12-03 Ｔｔｉ・エルビュー株式会社 自己組織性樹脂状高分子を有する送達装置及びその使用方法
KR20090106492A (ko) * 2006-12-01 2009-10-09 티티아이 엘뷰 가부시키가이샤 경피성 전달 장치와 같은 장치에 전력을 제공하거나 제어하기 위한 시스템, 장치, 및 방법
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US20100036269A1 (en) * 2008-08-07 2010-02-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US9672471B2 (en) 2007-12-18 2017-06-06 Gearbox Llc Systems, devices, and methods for detecting occlusions in a biological subject including spectral learning
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
WO2009158032A1 (en) * 2008-06-25 2009-12-30 Fe2, Inc. Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
US8150525B2 (en) * 2008-08-27 2012-04-03 Johnson & Johnson Consumer Companies, Inc. Treatment of hyperhydrosis
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US9008765B2 (en) 2009-02-12 2015-04-14 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US8348922B2 (en) * 2009-02-12 2013-01-08 Incube Labs, Llc Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
US8821945B2 (en) * 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
US8417330B2 (en) * 2009-06-26 2013-04-09 Incube Labs, Llc Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use
US8903485B2 (en) 2009-08-06 2014-12-02 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US8744567B2 (en) * 2009-11-13 2014-06-03 Johnson & Johnson Consumer Companies, Inc. Galvanic skin treatment device
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
WO2011100376A2 (en) 2010-02-10 2011-08-18 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
US10342968B2 (en) * 2010-12-22 2019-07-09 Teikoku Seiyaku Co., Ltd. Electrode pad used for iontophoresis treatment
EP3626304A1 (en) 2011-03-24 2020-03-25 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents
WO2014207750A1 (en) * 2013-06-28 2014-12-31 Yosef Gross International Technologies Ltd. Skin-care system
JP7285259B2 (ja) * 2017-09-12 2023-06-01 エルテーエス ローマン テラピー－ジステーメ アーゲー イオントフォレーシス用マイクロニードルデバイス
JP2025096725A (ja) * 2022-05-30 2025-06-30 キッコーマン株式会社 経皮通電パッチ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
US5068226A (en) * 1987-12-07 1991-11-26 Cyclex, Inc. Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
US5320597A (en) * 1991-02-08 1994-06-14 Becton, Dickinson And Company Device and method for renewing electrodes during iontophoresis
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.

Also Published As

Publication number Publication date
EP0805706A1 (fr) 1997-11-12
JP2006341107A (ja) 2006-12-21
DE69608248D1 (de) 2000-06-15
EP0805706B1 (fr) 2000-05-10
US5928185A (en) 1999-07-27
AU4626196A (en) 1996-08-14
ATE192664T1 (de) 2000-05-15
DE69608248T2 (de) 2001-01-04
FR2729574A1 (fr) 1996-07-26
PT805706E (pt) 2000-10-31
GR3034097T3 (en) 2000-11-30
WO1996022808A1 (fr) 1996-08-01
FR2729574B1 (fr) 1997-07-04
DK0805706T3 (da) 2000-10-02
JP3856240B2 (ja) 2006-12-13
JPH10512776A (ja) 1998-12-08

Similar Documents

Publication Publication Date Title
ES2154397T3 (es) Dispositivo de ionoforesis para la administracion transcutanea de un principio activo de tipo oligosacarido anionico.
CA2002849C (en) Method and apparatus for iontophoretic drug delivery
KR940006527B1 (ko) 이온침투 처리 시스템
US6223076B1 (en) Sweat control system
DE69427526D1 (de) Applikator zur transkutanen verabreichung eines medikaments
MXPA02011842A (es) Dispositivo de suministro electrocinetico.
DE69133328D1 (de) Vorrichtung zur iontophoretischen verabreichung
WO2003015863A3 (en) Gradual recruitment of muscle/neural excitable tissue using high-rate electrical stimulation parameters
EP1195175A3 (en) Iontoporesis device
BR0308438A (pt) Elétrodo biomédico e método para obter e transmitir sinais elétricos de origem eletrofisiológica ou eletrobiológica de um paciente
WO2002074384A3 (en) Methods, systems and devices for in vivo electrochemical production of therapeutic agents
JP2005506158A (ja) 経皮パッチ
ES8200561A1 (es) Una venda autonoma flexible
CA2001444A1 (en) Iontophoresis electrode
EP0016011A1 (en) Electrical stimulation dental device
WO2001079706A3 (en) Electrolytic cell
KR890009423A (ko) 전극을 이용하여 피부상해를 극소화시키는 방법 및 정치
CA2132348A1 (en) User Activated Iontophoretic Device and Method for Using Same
MX170809B (es) Electrodo de iontoforesis
EP1163025B1 (en) Sweat control system
JP2821267B2 (ja) イオン導入法によって薬剤を供給する装置および方法
CA2211794A1 (fr) Dispositif d'ionophorese pour l'administration transcutanee d'un principe actif de type oligosaccharide anionique
ITPA950015A1 (it) Spazzolino elettronico per ionoforesi dentale
CN110496306A (zh) 密合式电离牙齿美白仪
JPS6316344Y2 (es)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 805706

Country of ref document: ES